Copper Tripeptide-1 100mg is a high-purity, lyophilized metallopeptide complex designed specifically for in vitro molecular assays and preclinical biochemical investigation. Synthesized under strict USA manufacturing protocols, this research compound allows investigators to evaluate extracellular matrix remodeling, enzymatic activity, and gene modulation in controlled laboratory environments.
Copper Tripeptide-1 100mg is a high-purity, lyophilized metallopeptide complex designed specifically for in vitro molecular assays and preclinical biochemical investigation. Synthesized under strict USA manufacturing protocols, this research compound allows investigators to evaluate extracellular matrix remodeling, enzymatic activity, and gene modulation in controlled laboratory environments.
Copper Tripeptide-1 100mg is a high-purity, lyophilized metallopeptide complex consisting of the amino acid sequence glycyl-L-histidyl-L-lysine chelated with ionic copper (Cu2+). Formulated exclusively for in vitro assaying and preclinical laboratory research, this 100mg preparation enables structural bio-molecular investigation into collagen expression, cellular remodeling, and extracellular matrix regulation.
In laboratory settings, the chelated copper ion plays a critical structural and functional role in stabilizing the tripeptide backbone. This coordination complex enhances affinity toward specific cell-surface receptors and enzyme systems. When sourced through PX1 Research, every batch of Copper Tripeptide-1 100mg undergoes rigorous validation to guarantee precise stoichiometry and minimal unchelated free copper.
The molecular architecture of Copper Tripeptide-1 (chemically designated as Cu-GHK) relies on the specific spatial arrangement of the tripeptide sequence Gly-His-Lys coupled to divalent copper. The histidine imidazole ring, the alpha-amino group of glycine, and the nitrogen atoms of the peptide bonds form a stable coordination sphere around the copper ion. This spatial configuration protects the peptide bond from immediate enzymatic cleavage in cellular media.
Preclinical biochemistry models demonstrate that the equilibrium association constant of GHK for Cu2+ is exceptionally high ($K_a \approx 10^{16} \text{ M}^{-1}$), allowing it to readily compete with other biological ligands for divalent copper. This strong binding affinity ensures that during in vitro assays, the peptide remains complexed, providing researchers with a reliable model to evaluate copper transport, cellular uptake, and metalloprotein interaction pathways without localized heavy metal toxicity.
In vitro data indicate that Copper Tripeptide-1 acts as a regulator of extracellular matrix (ECM) biosynthesis and degradation balance. Cell culture studies utilizing human dermal fibroblasts have demonstrated that exposure to Cu-GHK upregulates the transcription of messenger RNA for collagen types I and III, as well as elastin and structural glycosaminoglycans. These genomic findings suggest a targeted stimulation of structural protein synthesis within the dermal matrix.
Beyond basic structural protein expression, preclinical literature reveals that Copper Tripeptide-1 influences the activity of matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs). In controlled fibroblast cultures, the complex balances MMP-1 and MMP-2 expression with TIMP-1 and TIMP-2 upregulation. This dual regulatory mechanism indicates that the peptide does not merely induce uncontrolled tissue deposition, but rather promotes a regulated remodeling phenotype suitable for studying tissue scaffold engineering and cellular repair kinetics.
Transcriptomic profiling in laboratory models suggests that Copper Tripeptide-1 modulates thousands of human genes involved in cellular defense, antioxidant pathways, and tissue integrity. Studies utilizing DNA microarrays highlight significant gene expression shifts in pathways controlling transforming growth factor-beta (TGF-$\beta$) signaling, integrin cell-adhesion molecules, and heat shock proteins.
In vitro assays examining inflammatory cascades show that Cu-GHK suppresses the transcription of key pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-$\alpha$). By mitigating oxidative stress markers and reactive oxygen species (ROS) accumulation in cultured cell lines, researchers utilize this complex to map intracellular redox signaling and genomic stabilization pathways under experimental stress conditions. Investigators interested in broader signaling studies can browse our full catalog of research peptides to design multi-target assay protocols.
When designing comparative in vitro trials, researchers frequently evaluate Copper Tripeptide-1 alongside related metallopeptides and signal peptides to map relative binding kinetics and downstream enzymatic stimulation. For example, unchelated GHK peptide serves as a control to isolate the specific biological contributions of the chelated divalent copper ion versus the isolated peptide sequence. Similarly, alternative copper-binding sequences like AHK-Cu are evaluated in follicular and endothelial cell lines to compare target receptor selectivity.
In broader tissue engineering and regenerative signaling models, researchers often benchmark Copper Tripeptide-1 against non-metal-binding repair peptides such as BPC-157 and TB-500. While BPC-157 and TB-500 act primarily through nitric oxide pathways, actin sequestration, and focal adhesion kinase stimulation, Copper Tripeptide-1 uniquely combines copper transport signaling with direct enzymatic cofactor delivery for lysyl oxidase and superoxide dismutase. These mechanistic distinctions allow investigators to establish specialized co-culture and comparative screening models in our extensive research library.
Maintaining rigorous analytical standards is essential for reproducing scientific results in preclinical research. Substandard or impure peptide preparations introduce uncontrolled variables that alter gene expression profiles and cell viability assays. PX1 Research subjects every batch of copper tripeptide-1 100mg to stringent quality control methodologies in fully accredited facilities.
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline chemical purity exceeding 98.0%. Molecular identity is definitively confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular mass and chelation characteristics. Furthermore, because bacterial pyrogens can interfere with cell signaling and provoke non-specific immune responses in vitro, all lots undergo chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below <0.01 EU/mg.
For optimal stability and assay fidelity, proper laboratory reconstitution procedures must be followed. Copper Tripeptide-1 100mg is supplied as a lyophilized blue cake or powder. Due to its hydrophilic nature and ionic charge, it dissolves readily in aqueous buffer systems, including sterile bacteriostatic water, sterile normal saline (0.9% NaCl), or phosphate-buffered saline (PBS, pH 7.4).
Reconstitution should take place under a certified laminar flow hood using sterile laboratory techniques. Investigators should avoid vigorous vortexing or mechanical agitation, which can induce physical shear stress on the peptide backbone; gentle swirling is recommended to achieve full dissolution. Once reconstituted, stock solutions should be filtered through a 0.22-micron polyethersulfone (PES) low-protein-binding syringe filter if absolute sterility for sensitive cell cultures is required.
Lyophilized Copper Tripeptide-1 100mg should be stored at -20°C or -80°C in a desiccated environment upon arrival. Sealed lyophilized vials stored at sub-zero temperatures remain chemically stable and resist degradation for up to 24 months. Exposure to moisture, direct ultraviolet light, and ambient temperatures above room temperature should be minimized to prevent premature cleavage or oxidation.
Reconstituted liquid aliquots should be used immediately or stored at -20°C to -80°C in working volumes to eliminate repeated freeze-thaw cycles. Multiple freeze-thaw cycles can cause physical stress, leading to peptide aggregation or copper dissociation. Reconstituted solutions kept at 4°C should be utilized within 7 to 14 days to ensure maximum bio-activity in enzymatic and transcriptional assays.
PX1 Research serves as a premier USA supplier of verified research-grade peptides, providing academic institutions, biotechnology organizations, and independent laboratories with highly reliable research compounds. Our USA-based synthesis and analytical infrastructure eliminates supply chain instability, guaranteeing consistent lot-to-lot purity and reliable mass spectra.
Every shipment from PX1 includes access to a lot-specific Certificate of Analysis (COA) detailing RP-HPLC chromatograms, mass spectrometry profiles, and endotoxin assay results. Fast dispatch directly from our California and Arizona logistics hubs ensures minimal transit time and temperature degradation. Institutional laboratories requiring bulk volume procurement or specialized account management can access tailored options through our wholesale program.
What is the molecular weight and chemical formula of Copper Tripeptide-1?
Copper Tripeptide-1 (Cu-GHK) has a chemical formula of C14H22CuN6O4 and a average molecular mass of approximately 401.91 g/mol in its complexed form.
How should Copper Tripeptide-1 100mg be reconstituted for in vitro assays?
Reconstitute the 100mg lyophilized powder using sterile PBS, normal saline, or bacteriostatic water under a laminar flow hood. Gently swirl until fully dissolved, avoiding aggressive mechanical vortexing.
What purity level is guaranteed for PX1 Copper Tripeptide-1?
PX1 Research guarantees a minimum purity of 98.0% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry analysis.
Is Copper Tripeptide-1 100mg approved for human administration or topical cosmetic use?
No. Copper Tripeptide-1 100mg supplied by PX1 Research is strictly sold as a research compound for laboratory and in vitro investigation only. It is not for human, clinical, veterinary, or cosmetic application.
How is endotoxin content measured and controlled?
Endotoxin levels are measured using standard Chromogenic Limulus Amebocyte Lysate (LAL) testing, ensuring every batch maintains endotoxin levels below <0.01 EU/mg.
What are the recommended storage temperatures for lyophilized vs reconstituted peptide?
Lyophilized vials should be stored at -20°C or -80°C for long-term stability. Reconstituted liquid aliquots should be stored at -20°C or -80°C and protected from repeated freeze-thaw cycles.
What is the primary difference between GHK and Copper Tripeptide-1?
GHK refers to the free tripeptide sequence (glycyl-L-histidyl-L-lysine), whereas Copper Tripeptide-1 (Cu-GHK) is the chelated metallopeptide complex bound to a divalent copper ion (Cu2+).
Where are PX1 research peptides manufactured and shipped from?
PX1 Research peptides are synthesized in USA-based GMP-compliant facilities and shipped directly from state-of-the-art dispatch centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.